Clinical Trials Directory

Trials / Completed

CompletedNCT04539288

Serum Biomarkers Associated With Postpartum T2DM in Women With GDM

Pregnancy to Postpartum Transition of Serum Biomarkers in Women With Gestational Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
3,099 (actual)
Sponsor
First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Gestational diabetes mellitus (GDM) is commonly linked to the development of type 2 diabetes mellitus (T2DM). There is a need to characterize metabolic changes associated with GDM in order to find novel biomarkers for T2DM.

Detailed description

GDM, a common complication of pregnancy, affects 17.8% of pregnancies worldwide per year. Women with a history of GDM have an approximately 7-fold higher risk for developing T2DM in the future than women without GDM. However, data on the factors associated with the development of T2DM in women with GDM are not widely available.

Conditions

Interventions

TypeNameDescription
OTHERThere is no intervention in this study.

Timeline

Start date
2013-05-01
Primary completion
2018-05-30
Completion
2018-05-30
First posted
2020-09-04
Last updated
2020-09-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04539288. Inclusion in this directory is not an endorsement.

Serum Biomarkers Associated With Postpartum T2DM in Women With GDM (NCT04539288) · Clinical Trials Directory